80 FR 38467 - Manufacturer of Controlled Substances Registration: Rhodes Technologies
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 80, Issue 128 (July 6, 2015)
Drug Enforcement Administration
Federal Register Volume 80, Issue 128 (July 6, 2015)
| Page Range | 38467-38468 | |
| FR Document | 2015-16458 |
[Federal Register Volume 80, Number 128 (Monday, July 6, 2015)] [Notices] [Pages 38467-38468] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-16458] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Manufacturer of Controlled Substances Registration: Rhodes Technologies ACTION: Notice of registration. ----------------------------------------------------------------------- SUMMARY: Rhodes Technologies applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Rhodes Technologies registration as a manufacturer of those controlled substances. SUPPLEMENTARY INFORMATION: By notice dated January 21, 2015, and published in the Federal Register on January 28, 2015, 80 FR 4593, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816 applied to be registered as a manufacturer of certain basic classes of controlled substances. One objection was received on March 27, 2015. However, after a thorough review of this matter, the Drug Enforcement Administration has concluded that the issues raised in the objection do not warrant the denial of this application. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Rhodes Technologies to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company's maintenance [[Page 38468]] of effective controls against diversion by inspecting and testing the company's physical security systems, verifying the company's compliance with state and local laws, and reviewing the company's background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above-named company is granted registration as a bulk manufacturer of the basic classes of controlled substances: ------------------------------------------------------------------------ Controlled substance Schedule ------------------------------------------------------------------------ Tetrahydrocannabinols (7370)............... I Methylphenidate (1724)..................... II Codeine (9050)............................. II Dihydrocodeine (9120)...................... II Oxycodone (9143)........................... II Hydromorphone (9150)....................... II Hydrocodone (9193)......................... II Levorphanol (9220)......................... II Morphine (9300)............................ II Oripavine (9330)........................... II Thebaine (9333)............................ II Oxymorphone (9652)......................... II Noroxymorphone (9668)...................... II Tapentadol (9780).......................... II Fentanyl (9801)............................ II ------------------------------------------------------------------------ The company plans to manufacture the above-listed controlled substances in bulk for conversion and sale to dosage form manufacturers. In reference to drug code 7370, the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activity for this drug code is authorized for this registration. Dated: June 25, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015-16458 Filed 7-2-15; 8:45 am] BILLING CODE 4410-09-P
![Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices 38467
Dated: June 25, 2015. form (FDF) from foreign sources for California 95670 applied to be registered
Joseph T. Rannazzisi, analytical testing and clinical trials in as a bulk manufacturer of the following
Deputy Assistant Administrator. which the foreign FDF will be compared basic classes of controlled substances:
[FR Doc. 2015–16456 Filed 7–2–15; 8:45 am] to the company’s own domestically-
BILLING CODE 4410–09–P manufactured FDF. This analysis is Controlled substance Schedule
required to allow the company to export
Methylphenidate (1724) ................ II
domestically-manufactured FDF to
Thebaine (9333) ........................... II
DEPARTMENT OF JUSTICE foreign markets. Poppy Straw Concentrate (9670) II
Dated: June 25, 2015. Tapentadol (9780) ........................ II
Drug Enforcement Administration
Joseph T. Rannazzisi,
[Docket No. DEA–392] Deputy Assistant Administrator. The company is a contract
manufacturer. In reference to Poppy
[FR Doc. 2015–16444 Filed 7–2–15; 8:45 am]
Importer of Controlled Substances Straw Concentrate the company will
BILLING CODE 4410–09–P
Application: Kremers Urban manufacture thebaine intermediates for
Pharmaceuticals, Inc. sale to its customers for further
DEPARTMENT OF JUSTICE manufacture. No other activity for this
ACTION: Notice of application. drug code is authorized for this
Drug Enforcement Administration registration.
DATES: Registered bulk manufacturers of
the affected basic class, and applicants [Docket No. DEA–392] Dated: June 25, 2015.
therefore, may file written comments on Joseph T. Rannazzisi,
or objections to the issuance of the Bulk Manufacturer of Controlled Deputy Assistant Administrator.
proposed registration in accordance Substances Application: AMPAC Fine [FR Doc. 2015–16443 Filed 7–2–15; 8:45 am]
with 21 CFR 1301.34(a) on or before Chemicals LLC BILLING CODE 4410–09–P
August 5, 2015. Such persons may also
file a written request for a hearing on ACTION: Notice of application.
the application pursuant to 21 CFR DEPARTMENT OF JUSTICE
DATES: Registered bulk manufacturers of
1301.43 on or before August 5, 2015.
the affected basic classes, and Drug Enforcement Administration
ADDRESSES: Written comments should
applicants therefore, may file written
be sent to: Drug Enforcement comments on or objections to the [Docket No. DEA–392]
Administration, Attention: DEA Federal issuance of the proposed registration in
Register Representative/ODXL/8701 Manufacturer of Controlled
accordance with 21 CFR 1301.33(a) on
Morrissette Drive, Springfield, Virginia Substances Registration: Rhodes
or before September 4, 2015.
22152. Request for hearings should be Technologies
ADDRESSES: Written comments should
sent to: Drug Enforcement
Administration, Attention: Hearing be sent to: Drug Enforcement ACTION: Notice of registration.
Clerk/LJ, 8701 Morrissette Drive, Administration, Attention: DEA Federal
Register Representative/ODXL, 8701 SUMMARY: Rhodes Technologies applied
Springfield, Virginia 22152. to be registered as a manufacturer of
Morrissette Drive, Springfield, Virginia
SUPPLEMENTARY INFORMATION: The certain basic classes of controlled
22152. Request for hearings should be
Attorney General has delegated his substances. The Drug Enforcement
sent to: Drug Enforcement
authority under the Controlled Administration (DEA) grants Rhodes
Administration, Attention: Hearing
Substances Act to the Administrator of Technologies registration as a
the Drug Enforcement Administration Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152. manufacturer of those controlled
(DEA), 28 CFR 0.100(b). Authority to substances.
exercise all necessary functions with SUPPLEMENTARY INFORMATION: The
respect to the promulgation and Attorney General has delegated his SUPPLEMENTARY INFORMATION: By notice
implementation of 21 CFR part 1301, authority under the Controlled dated January 21, 2015, and published
incident to the registration of Substances Act to the Administrator of in the Federal Register on January 28,
manufacturers, distributors, dispensers, the Drug Enforcement Administration 2015, 80 FR 4593, Rhodes Technologies,
importers, and exporters of controlled (DEA), 28 CFR 0.100(b). Authority to 498 Washington Street, Coventry, Rhode
substances (other than final orders in exercise all necessary functions with Island 02816 applied to be registered as
connection with suspension, denial, or respect to the promulgation and a manufacturer of certain basic classes
revocation of registration) has been implementation of 21 CFR part 1301, of controlled substances. One objection
redelegated to the Deputy Assistant incident to the registration of was received on March 27, 2015.
Administrator of the DEA Office of manufacturers, distributors, dispensers, However, after a thorough review of this
Diversion Control (‘‘Deputy Assistant importers, and exporters of controlled matter, the Drug Enforcement
Administrator’’) pursuant to section 7 of substances (other than final orders in Administration has concluded that the
28 CFR part 0, appendix to subpart R. connection with suspension, denial, or issues raised in the objection do not
In accordance with 21 CFR revocation of registration) has been warrant the denial of this application.
1301.34(a), this is notice that on January redelegated to the Deputy Assistant The DEA has considered the factors in
12, 2015, Kremers Urban Administrator of the DEA Office of 21 U.S.C. 823(a) and determined that
Pharmaceuticals, Inc., 1101 C Avenue Diversion Control (‘‘Deputy Assistant the registration of Rhodes Technologies
Lhorne on DSK7TPTVN1PROD with NOTICES
West, Seymour, Indiana 47274 applied Administrator’’) pursuant to section 7 of to manufacture the basic classes of
to be registered as an importer of 28 CFR part 0, appendix to subpart R. controlled substances is consistent with
methylphenidate (1724), a basic class of In accordance with 21 CFR the public interest and with United
controlled substance listed in schedule 1301.33(a), this is notice that on March States obligations under international
II. 20, 2015, AMPAC Fine Chemicals LLC, treaties, conventions, or protocols in
The company plans to import the Highway 50 and Hazel Avenue, effect on May 1, 1971. The DEA
listed substances in finished dosage Building 05001, Rancho Cordova, investigated the company’s maintenance
VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\06JYN1.SGM 06JYN1](https://thefederalregister.org/doc/80_FR_38595/page/1.svg)
![38468 Federal Register / Vol. 80, No. 128 / Monday, July 6, 2015 / Notices
of effective controls against diversion by synthetic tetrahydrocannabinol. No Register Representative/ODXL, 8701
inspecting and testing the company’s other activity for this drug code is Morrissette Drive, Springfield, Virginia
physical security systems, verifying the authorized for this registration. 22152. Request for hearings should be
company’s compliance with state and Dated: June 25, 2015. sent to: Drug Enforcement
local laws, and reviewing the company’s Joseph T. Rannazzisi,
Administration, Attention: Hearing
background and history. Clerk/LJ, 8701 Morrissette Drive,
Therefore, pursuant to 21 U.S.C. Deputy Assistant Administrator.
Springfield, Virginia 22152.
823(a), and in accordance with 21 CFR [FR Doc. 2015–16458 Filed 7–2–15; 8:45 am]
SUPPLEMENTARY INFORMATION: The
1301.33, the above-named company is BILLING CODE 4410–09–P
Attorney General has delegated his
granted registration as a bulk
authority under the Controlled
manufacturer of the basic classes of
DEPARTMENT OF JUSTICE Substances Act to the Administrator of
controlled substances:
the Drug Enforcement Administration
Controlled substance Schedule Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to
[Docket No. DEA–392]
exercise all necessary functions with
Tetrahydrocannabinols (7370) ..... I respect to the promulgation and
Methylphenidate (1724) ................ II Importer of Controlled Substances implementation of 21 CFR part 1301,
Codeine (9050) ............................. II incident to the registration of
Dihydrocodeine (9120) ................. II
Application: Lipomed, Inc.
manufacturers, distributors, dispensers,
Oxycodone (9143) ........................ II
Hydromorphone (9150) ................ II ACTION: Notice of application. importers, and exporters of controlled
Hydrocodone (9193) ..................... II substances (other than final orders in
Levorphanol (9220) ...................... II DATES: Registered bulk manufacturers of connection with suspension, denial, or
Morphine (9300) ........................... II the affected basic classes, and revocation of registration) has been
Oripavine (9330) ........................... II applicants therefore, may file written redelegated to the Deputy Assistant
Thebaine (9333) ........................... II comments on or objections to the Administrator of the DEA Office of
Oxymorphone (9652) ................... II issuance of the proposed registration in Diversion Control (‘‘Deputy Assistant
Noroxymorphone (9668) .............. II accordance with 21 CFR 1301.34(a) on Administrator’’) pursuant to section 7 of
Tapentadol (9780) ........................ II
Fentanyl (9801) ............................ II or before August 5, 2015. Such persons 28 CFR part 0, appendix to subpart R.
may also file a written request for a In accordance with 21 CFR
The company plans to manufacture hearing on the application pursuant to 1301.34(a), this is notice that on March
the above-listed controlled substances 21 CFR 1301.43 on or before August 5, 31, 2014, Lipomed, Inc., One Broadway,
in bulk for conversion and sale to 2015. Cambridge, Massachusetts 02142
dosage form manufacturers. ADDRESSES: Written comments should applied to be registered as an importer
In reference to drug code 7370, the be sent to: Drug Enforcement of the following basic classes of
company plans to bulk manufacture a Administration, Attention: DEA Federal controlled substances:
Controlled substance Schedule
Cathinone (1235) .................................................................................................................................................................................. I
Methcathinone (1237) ........................................................................................................................................................................... I
Mephedrone (4-Methyl-N-methylcathinone) (1248) .............................................................................................................................. I
N-Ethylamphetamine (1475) ................................................................................................................................................................. I
N,N-Dimethylamphetamine (1480) ........................................................................................................................................................ I
Fenethylline (1503) ............................................................................................................................................................................... I
Aminorex (1585) .................................................................................................................................................................................... I
4-Methylaminorex (cis isomer) (1590) .................................................................................................................................................. I
Gamma Hydroxybutyric Acid (2010) ..................................................................................................................................................... I
Methaqualone (2565) ............................................................................................................................................................................ I
Mecloqualone (2572) ............................................................................................................................................................................ I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) ............................................................................................................ I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) (7008) .......................................................... I
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) ................................................................................................................................ I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) (7081) ............................................................................................................ I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) .............................................................................. I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl) indole) (7118) ...................................................................................... I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) (7122) ............................................................................................................... I
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) (7173) ................................................................................................................................. I
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole) (7200) ................................................................................................... I
AM–2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) (7201) ............................................................................................................... I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) (7203) ................................................................................................................ I
Alpha-ethyltryptamine (7249) ................................................................................................................................................................ I
Ibogaine (7260) ..................................................................................................................................................................................... I
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) .......................................................................... I
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) .................................................... I
Lysergic acid diethylamide (7315) ........................................................................................................................................................ I
Lhorne on DSK7TPTVN1PROD with NOTICES
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) (7348) ........................................................................................................ I
Marihuana (7360) .................................................................................................................................................................................. I
Tetrahydrocannabinols (7370) .............................................................................................................................................................. I
Parahexyl (7374) ................................................................................................................................................................................... I
Mescaline (7381) ................................................................................................................................................................................... I
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2) (7385) ..................................................................................................... I
3,4,5-Trimethoxyamphetamine (7390) .................................................................................................................................................. I
4-Bromo-2,5-dimethoxyamphetamine (7391) ....................................................................................................................................... I
VerDate Sep<11>2014 14:37 Jul 02, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\06JYN1.SGM 06JYN1](https://thefederalregister.org/doc/80_FR_38595/page/2.svg)
Document Created: 2015-12-15 13:17:18
Document Modified: 2015-12-15 13:17:18
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of registration. | |
| FR Citation | 80 FR 38467 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR